Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- LAUREL
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
-
Autoimmune Disorder -
Inflammatory Bowel Disease (IBD) -
Ulcerative Colitis
- Results
-
Download -
Study results
LPS_GA29102_LAUREL_interim results_October2021_English
(PDF, 0.6 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_cs
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_da
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_de
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_es
(PDF, 0.3 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_fr
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_he
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_hu
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_it
(PDF, 0.3 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_pl
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_pt
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_sl
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_22Nov2021_English_uk
(PDF, 0.4 MB)
LPS_GA29102_LOUREL_final results_October2021_English_India
(PDF, 0.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com